Nisa Investment Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Nisa Investment Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19	Closed	-$804	–	2991
2024 Q1	$804	Buy	19 +6	+46%	+$253	﹤0.01%	2409
2023 Q4	$543	Hold	13	–	–	﹤0.01%	2389
2023 Q3	$490	Hold	13	–	–	﹤0.01%	2534
2023 Q2	$493	Buy	+13	New	+$408	﹤0.01%	2564
2020 Q2	–	Sell	-56	Closed	-$3K	–	2115
2020 Q1	$3K	Hold	56	–	–	﹤0.01%	2026
2019 Q4	$5K	Hold	56	–	–	﹤0.01%	1934
2019 Q3	$4K	Hold	56	–	–	﹤0.01%	1941
2019 Q2	$5K	Buy	+56	New	+$5.54K	﹤0.01%	1909
2017 Q4	–	Sell	-8,800	Closed	-$992K	–	1859
2017 Q3	$992K	Buy	+8,800	New	+$958K	0.01%	827

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

GCM

Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Nisa Investment Advisors's TARO Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 19 shares — an estimated $804 sold.

Nisa Investment Advisors first reported a position in TARO in Q3 2017 and held it in 9 quarters. The position peaked at $992K in Q3 2017. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

Nisa Investment Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
Nisa Investment Advisors sold 19 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $804.
Nisa Investment Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2017 and held it in 9 quarters.
Nisa Investment Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $992K in Q3 2017.
16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.